RIP: Making Prescription Drugs Affordable: The National Academies of Sciences, Engineering and Medicine's Report

This event has reached capacity.  If you would like to be added to the waitlist, please contact Adreana at pinuelas@stanford.edu.

"Making Prescription Drugs Affordable: The National Academies of Sciences, Engineering and Medicine's Report"

In a recent poll, Americans ranked prescription drug prices as the most important domestic issue for Congress to tackle.  Prescription drugs now account for 17% of national health care expenditures, and 1 in 4 Americans reports that they or a family member has decided not to fill a prescription or to skip or reduce doses in the past year because of cost worries.  To investigate the causes of high drug costs and potential policy interventions, the National Academies of Sciences, Engineering and Medicine convened a committee of experts, which recently released its report.  Dr. Mello, a member of the committee, will review the key findings and discuss factors that make the affordability of medicines such a difficult problem to solve.

Please note: All research in progress seminars are off-the-record unless otherwise noted. Any information about methodology and/or results are embargoed until publication.